25 Million for Paediatric Research
June 18, 2015
Minister for Health Jillian Skinner and Minister for Medical Research Pru Goward have visited The Children’s Hospital at Westmead to announce the 2015-16 Budget will include $25 million for paediatric research to unlock treatments and cures.
Mrs Skinner said a centrepiece of the investment will be the establishment of Australia’s largest clinical trials centre exclusively for paediatric research.
The $6 million centre will be built at the Kids Research Institute (KRI) at Westmead.
“Paediatric researchers from across NSW – including the KRI, the Children’s Medical Research Institute (CMRI) at Westmead and the Children’s Cancer Institute (CCI) at Randwick – will have access to this centre, allowing them to continue their dedicated pursuit of life-saving treatments and cures,” Mrs Skinner said.
“The NSW Government made a pre-election commitment to deliver $25 million for paediatric medical research and the Budget will deliver it in full.”
The $25 million investment will also include:
- $5.5 million upgrade to facilities, equipment and technology across the three main research facilities – KRI, CMRI and CCI
- $1 million to enhance the Gene Vector Lab at CMRI
- $10 million to relocate all paediatric research across the Sydney Children’s Hospital at Randwick to one floor of the Nelune building, as part of the Bright Alliance
- $2.5 million to upgrade and increase lab space for the personalised medicine program at the Children’s Cancer Institute at Randwick
Ms Goward said the funding boost offers hope to families and researchers in the fight against childhood disease.
“The NSW Budget will continue cementing NSW’s reputation as a centre of research excellence where the best and brightest choose to work,” Ms Goward said.
About Children’s Cancer Institute
Originally founded by two fathers of children with cancer in 1976, Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to research into the causes, prevention and cure of childhood cancer. Forty years on, our vision remains unchanged – to save the lives of all children with cancer and to eliminate their suffering. The Institute has grown to now employ more than 220 researchers, operational staff and students, and has established a national and international reputation for scientific excellence.
Our focus is on translational research, and we have an integrated team of laboratory researchers and clinician scientists who work together in partnership to discover new treatments which can be progressed from the lab bench to the beds of children on wards in our hospitals as quickly as possible. These new treatments are specifically targeting childhood cancers, so we can develop safer and more effective drugs and drug combinations that will minimise side-effects and ultimately give children with cancer the best chance of a cure with the highest possible quality of life.
We are currently leading the establishment of the Zero Childhood Cancer national child cancer personalised medicine program for children with the most aggressive cancers, in partnership with the Sydney Children’s Hospitals Network. This program will revolutionise the way treatment decisions are made, with the aim of improving survivorship for those children at highest risk of treatment failure from their disease.